(nontransplant, non-HIV-infected patients with CNS disease, severe pulmonary disease, or cryptococcemia/dissemination) 0.7 to 1 mg/kg/day IV plus flucytosine 100 mg/kg/day ORALLY in 4 divided doses for 4 to 6 weeks (induction), followed by fluconazole 400 mg/day ORALLY for 8 weeks (consolidation), then fluconazole 200 mg/day ORALLY for 6 to 12 months (maintenance) (guideline dosing)
(flucytosine-intolerant, nontransplant, non-HIV-infected patients with CNS disease, severe pulmonary disease, or cryptococcemia/dissemination) 0.7 to 1 mg/kg/day IV for at least 6 weeks (induction), followed by fluconazole 400 mg/day ORALLY for 8 weeks (consolidation), then fluconazole 200 mg/day ORALLY for 6 to 12 months (maintenance)